|Gary L. Smith, MBA|
Gary Smith is CEO of Clevex Ltd. (Cleveland), which develops surgical dermatology devices. He is also director of the Business Technology Center, Bioincubator, in Columbus, OH, and interim CEO of Prognostix Inc. Before taking the helm of Clevex, Mr. Smith was vice president of market and business development for the health and life science division of Battelle from 1996-2004. Prior to that, he held management positions with Gelman Science, Medex Inc., and Homewood Healthcare Products. He has a BS in physiology from the University of Toledo, an MBA from Temple University in Philadelphia, and a PhD in physiology from the Medical College of Ohio. He has been a member of MD&DI's Editorial Advisory Board since 2001.